DIXIE STONE: Open Payments
NPI 1265443006 · CYNTHIANA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 91 payments from 22 companies in 2025. Trend: 2023 $729 · 2024 $1,024 · 2025 $1,650
Food & beverage: $1,475Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $256 |
| ABBVIE INC. | 21 | $252 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $173 |
| Otsuka America Pharmaceutical, Inc. | 10 | $155 |
| Alkermes, Inc. | 5 | $98 |
| Insulet Corporation | 3 | $60 |
| Lundbeck LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $46 |
Products named: REXULTI, Kerendia, PROLIA, CAPLYTA, VRAYLAR, ARISTADA, OTEZLA, UBRELVY.
Industry payments across KY — which companies pay providers there.
